Home > Press release

 

 

ARCHIVE PRESS RELEASE
Chiesi Farmaceutici President appointed Knight of the Légion d’Honneur
18 Settembre 2020
Moderna and Chiesi Group Establish Collaboration to Discover and Develop mRNA Therapeutics for Pulmonary Arterial Hypertension (PAH).
17 Settembre 2020
Chiesi publishes its annual report: Group generates almost €2 billion and obtains B Corp certification in 2019
16 Luglio 2020
Bioasis and Chiesi Group to Host Webcast on July 16, 2020
10 Luglio 2020
Thomas Eichholtz appointed new Head of Global Research and Development at the Chiesi Group
02 Luglio 2020
Bioasis and Chiesi Group Announce Rare Diseases Strategic Alliance
29 Giugno 2020
Chiesi Group increases support measures and announces new funds for employees, patients and healthcare providers in response to COVID-19 pandemic
27 Marzo 2020
Chiesi Group Announces Establishment of New Global Rare Diseases Division
06 Febbraio 2020
Chiesi Group confirmed Top Employer 2020 in Italy and Europe
30 Gennaio 2020
Chiesi Group sponsors Parma Capital of Culture 2020
10 Gennaio 2020
© 2025 CHIESI Farmaceutici S.p.A.
VAT IT 01513360345
Company's Capital: Euro 75.000.000
Companies Register Office - Parma N.15739
REA: 159271

PHARMACOVIGILANCE

TO REPORT ADVERSE DRUG EVENTS/REACTIONS PLEASE CLICK HERE


follow us on: